The Dutch Huntington’s Disease Symposium provides a forum for research into the care and cure of Huntington’s Disease. The meeting will include topics such as molecular mechanisms, biomarkers, therapies and care in Huntington’s Disease, with a special focus on biomarkers.
Biomarkers in Huntington’s Disease
The diagnosis of Huntington’s Disease is based on clinical signs and symptoms. However, we know that many years before the clinical diagnosis is made, patients already show cognitive, behavioural and brain MRI changes. Detecting such changes is of huge importance related to future disease modifying treatments. Biomarkers can help monitor the disease development before clinical signs and symptoms arise. Biomarkers can be detected in fluids such as cerebrospinal fluid, blood or tears. They can also be detected by using imaging such as brain MRI or retinal imaging.
Focus on research on biomarkers in Huntington’s Disease
The Dutch Huntington’s Disease symposium
We hope that you will enjoy our very topical Huntington’s Disease symposium, take this opportunity to get to know your colleagues’ research better, and be inspired by our collective scientific work.
Dr. Mayke Oosterloo
Head of Huntington’s Disease Expertise Center Maastricht UMC+
